Stock Spotlights Archives - Page 2 of 19

FridayAug 16, 2024 2:51 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Opportunity from First-Ever Work with Tirzepatide Molecule

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently hired a Contract Research Organization (“CRO”) for its third human pilot study. “This marks a milestone for the company, notably since it announced its focus solely on glucagon-like peptide 1 (‘GLP-1’) studies for the 2024 calendar year… This randomized, crossover investigation will evaluate a dual-action GLP-1 + glucose-dependent insulintropic peptide (‘GIP’), specifically measuring absorption, tolerability, pharmacokinetics, and blood sugar levels. It will compare injected tirzepatide (Zepbound(R) by Eli Lilly) to a compound formulated, DehydraTECH-processed tirzepatide derived from Zepbound(R). The objective would be to evaluate whether DehydraTECH-processed tirzepatide,…

TuesdayAug 06, 2024 11:10 am

TinyGemsBreaks – Nightfood Holdings Inc. (NGTF) Expands into Growing Food-Service Segment with Recent Acquisition

Nightfood Holdings (OTCQB: NGTF), a forward-thinking acquisition and development holding company, has built a reputation in the sleep-friendly snack market. Now the company is expanding beyond the nighttime snack category into a growing segment of the food-service industry through recent acquisitions designed to diversify operations and capitalize on an emerging market. According to the article, Nightfood signed a letter of intent (“LOI “) to acquire SWC Group Inc., doing business as Carryoutsupplies.com, or CarryOut for short. CarryOut specializes in custom-printed food packaging and offers traditional and environmentally friendly selections for restaurants, cafes and other food-service businesses. “We are thrilled at…

MondayAug 05, 2024 12:57 pm

TinyGemsBreaks – ECGI Holdings Inc. (ECGI) Looking at Luxury Equestrian Market to Build Market Share

ECGI Holdings (OTC: ECGI), a diversified holding company focusing on viticulture, luxury fashion and equestrian markets, is eyeing segments of the luxury goods market as an opportunity to generate significant annual revenues. According to a recent article, ECGI believes the luxury apparel and accessories segments, which excludes broader categories such as watches, jewelry and beauty, make up about 50% of the luxury market in the United States and maybe even worldwide. The article notes that the luxury apparel and accessories segments are valued at approximately $37 billion in the U.S.; that could translate to revenues of between $370 million and…

ThursdayJul 18, 2024 2:58 pm

TinyGemsBreaks – GEMXX Corp. (GEMZ) Capitalizing on High-Potential Opportunities in Energy Sector

GEMXX (OTC: GEMZ), a publicly traded exploration company engaged in gold, gemstones, oil and gas, recently signed a definitive agreement with Latin Energy Partners (“LEP”) to drill four test wells in a promising geological formation in Latin America. “This strategic venture represents a significant milestone in GEMXX’s expansion into the energy sector, highlighting the company’s dedication to diversification, growth and enhancing shareholder value. Latin Energy Partners is a rising independent exploration and production company focused on discovering substantial hydrocarbon reserves in Latin America, an area with significant untapped potential… The drilling of the four test wells is set to begin…

FridayJul 12, 2024 1:30 pm

TinyGemsBreaks – GEMXX Corp. (GEMZ), Partner Positioned to Establish Footprint in Global Oil and Gas Market

GEMXX (OTC: GEMZ), a mine-to-market gold, gemstone and jewelry producer with global reach, recently entered a significant collaboration with Latin Energy Partners (“LEP”), an emerging leader and independent E&P company involved in the exploration of significant hydrocarbon reserves in Latin America. “GEMXX and LEP have defined the terms to jointly drill four test wells in a promising geological formation in a Latin American country. This partnership marks a landmark move for both companies in their oil exploration and development pursuits. The partnership particularly aligns with GEMXX’s long-term goals, with CEO Richard Clowater expressing his company’s eagerness to join forces with…

FridayMay 31, 2024 3:37 pm

TinyGemsBreaks – GEMXX Corp. (GEMZ) Aims to Establish Footprint in Global Energy Landscape

GEMXX (OTC: GEMZ), an established mine-to-market gem enterprise, recently announced that it is actively broadening its business framework to incorporate private equity funding for oil and gas (“O&G”) exploration ventures. “With a large network of global relationships and several strategic alliances recently established, GEMXX is setting the stage to finance the exploration of extensive oil reserves, specifically targeting giant fields with reserves of 500 million barrels and super-giant fields with over 3 billion barrels located primarily in Latin America,” a recent article reads. “By leveraging its comprehensive network in the O&G sector, which includes major global industry players, GEMXX plans…

MondayMay 20, 2024 3:00 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Poised as Go-to Brand for Reliable Cross-Border Shipping in USMCA Region

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a tech company that is transforming cross-border shipping by offering carriers and shippers unmatched flexibility, visibility and simplicity, has been at the forefront of pushing for reliable and dependable ways to organize, facilitate and monitor cross-border shipments, mainly through its Fr8App system. “The Fr8App is supported by artificial intelligence (‘AI’), machine learning and cloud computing, providing an unrivaled freight-matching platform with a real-time portal for B2B cross-border and domestic shipping. With Fr8App, connecting shippers with carriers and drivers is efficient and seamless,” a recent article reads. “Fr8App understands the complexities of cross-border logistics and knows…

ThursdayMay 16, 2024 3:22 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Tap into Various Growing Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, has proven in numerous studies the ability of its patented DehydraTECH(TM) technology to increase bio-absorption compared to standard industry formulations, as well as reduce time of onset and deliver drugs more effectively across the blood-brain barrier. “DehydraTECH has a number of potential pharmaceutical applications, a testament to its versatility and overall effectiveness. The key factor that has played a role in its adoption is its unique ability to improve drug bioavailability, a critical marker and determinant of overall drug effectiveness,” a recent article reads. “With this technology, Lexaria…

MondayApr 15, 2024 3:31 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Concentrating 2024 R&D Plans Mainly on GLP-1 Investigations

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced $3.6 million in gross proceeds from its registered direct offering. “Most notably, Lexaria intends to use the net proceeds from this offering for research and development (‘R&D’) studies and the associated patent and legal costs. It also intends to use the funds for general working capital purposes, important for its current focus on GLP-1 clinical studies for the 2024 calendar year… In 2023, Lexaria laid the groundwork for its GLP-1 clinical studies. The company achieved positive interim and final human pilot study results using a single…

MondayApr 15, 2024 1:37 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Represents Opportunity to Provide Solution for GBM Patients

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biopharmaceutical company advancing its lead drug candidate, Berubicin, along the pathway to potential regulatory approval and commercialization, recently appointed Amy Mahery to its board of directors. “A biotech commercialization leader, Ms. Mahery has built an illustrious career that spans more than 20 years. During this period, she has gained commercial expertise working with small and large companies in common and rare conditions, as well as across several therapeutic areas… Ms. Mahery lauded CNS Pharmaceuticals and its efforts to fill gaps in areas with high unmet medical needs, such as glioblastoma multiforme (‘GBM’) treatment, saying,…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: Stock Spotlights